Vita Coco CCO sells 2,000 shares in Form 4
Vita Coco Company, Inc. Chief Commercial Officer Charles van Es reported an open-market sale of 2,000 shares of Common Stock at $66.87 per share.
Rhea-AI Filing Summary
Vita Coco Company, Inc. Chief Commercial Officer Charles van Es reported an open-market sale of 2,000 shares of Common Stock at $66.87 per share. Following this sale, he directly holds 75,691 Common Stock shares. The filing also lists multiple outstanding non-qualified stock options that are vested or scheduled to vest over time, with exercise prices ranging from $10.178 to $33.36 per share and expiration dates extending through 2035. A footnote states the sale was executed under a pre-arranged Rule 10b5-1 trading plan.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 2,000 | $66.87 | $134K |
| holding | Non-Qualified Stock Option (Right to Buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (Right to Buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (Right to Buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (Right to Buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (Right to Buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (Right to Buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (Right to Buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (Right to Buy) | -- | -- | -- |
Footnotes (8)
- F1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
- F2. The stock option is fully vested and currently exercisable.
- F3. The stock option vests in four equal annual installments beginning on November 27, 2022.
- F4. The stock option vests in three equal annual installments beginning on August 15, 2025.
- F5. The stock option is eligible to vest if certain performance conditions are met by the target date for the applicable performance condition(s) and expire if the performance conditions are not met by the final target date. The performance conditions applicable were timely satisfied, resulting in vesting of the option as to 14,025 shares on February 20, 2026.
- F6. The stock options vest in four annual equal installments beginning on March 10, 2024.
- F7. The stock option vests in four equal annual installments beginning on March 4, 2025.
- F8. The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
Non-Qualified Stock Option (Right to Buy) financial
performance conditions financial
beneficially owned financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Vita Coco (COCO) report for Charles van Es?
Was the Vita Coco (COCO) insider sale by Charles van Es under a Rule 10b5-1 plan?
What stock options does Charles van Es hold in Vita Coco (COCO) according to this filing?
Are any of Charles van Es’s Vita Coco (COCO) stock options performance-based?
How do Charles van Es’s Vita Coco (COCO) options vest over time?
AI-generated analysis. How Rhea-AI works. Not financial advice.